As previously announced, Arraywill hold a teleconference on November7, 2025, at 9:00 a.m. CST.Listen to the call live via the Events & Presentations page ofinvestors.arrayinc.com. Array Digital Infrastructure, Inc. (NYSE:AD) reported total operating revenues from continuing operations of $47.1 million for the third quarter of 2025, versus $25.7 million for the same period one year […]

Array Digital Infrastructure, Inc.SM (NYSE: AD) (ArraySM), and Telephone and Data Systems, Inc. (NYSE: TDS) today announced Anthony Carlson will become the President and CEO of Array on November 16, 2025. Concurrently, Anthony Carlson will join the Array Board of Directors. As President and CEO of Array, he will be responsible for overseeing operations and

Announces new $500 million share repurchase authorization As previously announced,TDS will hold a teleconference on November7, 2025, at9:00 a.m. CST. Listen to the call live via the Events & Presentations page ofinvestors.tdsinc.com. Telephone and Data Systems, Inc. (NYSE:TDS) reported total operating revenues from continuing operations of $308.5 million for the third quarter of 2025, versus

Copyseeker Pioneers Visual Search Integration in AI with Model Context Protocol Launch GlobeNewswire November 07, 2025 Copyseeker announced today the launch of its Model Context Protocol (MCP) server, bringing reverse image search directly into AI assistants like ChatGPT, Claude, and Gemini. No more tab switching. No more copying and pasting URLs. Just seamless visual search

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments GlobeNewswire November 07, 2025 Single ascending dose data readout for VTP-1000 expected before the end of 2025 Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of 2026 Proposed combination with Clywedog Therapeutics Inc.

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 07, 2025 PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactions Company to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”)

Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE(R) (setmelanotide) for Patients with Acquired Hypothalamic Obesity GlobeNewswire November 07, 2025 — FDA sets updated PDUFA goal date of March 20, 2026 – — Company to hold conference today at 8:00 a.m. — BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM),

Almadex Announces Plans to Drill New Hope Porphyry Project, Arizona and Provides Paradise Drill Program Update GlobeNewswire November 07, 2025 VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide an update from its scout drilling program at the Paradise Project Nevada as

TERRA CLEAN PROVIDES CORPORATE UPDATE GlobeNewswire November 07, 2025 Vancouver B.C., Nov. 07, 2025 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) is pleased to announce that it has scheduled its annual general meeting of shareholders for December 8, 2025 (the “Meeting“). At that Meeting, amongst

Abeona Therapeutics(R) Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation GlobeNewswire November 07, 2025 CLEVELAND, Nov. 07, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, November 12, 2025 at 8:30 a.m. ET to discuss its third quarter 2025 financial results